Efficacy and safety of olanzapine in the treatment of patients with bipolar I disorder, depressed: a randomized, double-blind comparison with placebo.
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2012
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 23 Aug 2012 Results published in the British Journal of Psychiatry.
- 12 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History